Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
30350 | 170 | 28.5 | 58% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
275 | 3 | NSAIDS//CYCLOOXYGENASE//CYCLOOXYGENASE 2 | 43399 |
466 | 2 | NSAIDS//NON STEROIDAL ANTI INFLAMMATORY DRUGS//COX 2 INHIBITORS | 15930 |
30350 | 1 | LICOFELONE//TEPOXALIN//2 2 DIMETHYL 6 4 CHLOROPHENYL 7 PHENYL 2 3 DIHYDRO 1H PYRROLIZINE 5 YL ACETIC ACID | 170 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LICOFELONE | authKW | 1483135 | 10% | 49% | 17 |
2 | TEPOXALIN | authKW | 1207440 | 6% | 61% | 11 |
3 | 2 2 DIMETHYL 6 4 CHLOROPHENYL 7 PHENYL 2 3 DIHYDRO 1H PYRROLIZINE 5 YL ACETIC ACID | authKW | 898103 | 3% | 100% | 5 |
4 | ML3000 | authKW | 718482 | 2% | 100% | 4 |
5 | COX 5 LOX INHIBITOR | authKW | 404145 | 2% | 75% | 3 |
6 | CAS 156897 06 2 | authKW | 359241 | 1% | 100% | 2 |
7 | LOX COX INHIBITOR | authKW | 359241 | 1% | 100% | 2 |
8 | RWJ 20142 | authKW | 359241 | 1% | 100% | 2 |
9 | CYCLOOXYGENASE LIPOXYGENASE INHIBITOR | authKW | 239493 | 1% | 67% | 2 |
10 | ZLJ 6 | authKW | 239493 | 1% | 67% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 1040 | 46% | 0% | 78 |
2 | Chemistry, Medicinal | 791 | 21% | 0% | 35 |
3 | Chemistry, Organic | 194 | 16% | 0% | 28 |
4 | Rheumatology | 101 | 5% | 0% | 8 |
5 | Chemistry, Multidisciplinary | 94 | 18% | 0% | 30 |
6 | Veterinary Sciences | 18 | 5% | 0% | 8 |
7 | Geriatrics & Gerontology | 13 | 2% | 0% | 3 |
8 | Integrative & Complementary Medicine | 12 | 1% | 0% | 2 |
9 | Toxicology | 9 | 3% | 0% | 5 |
10 | Crystallography | 7 | 2% | 0% | 4 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ATHEROSCLEROSIS DYSMETABOL DIS STUDY GC DES | 179621 | 1% | 100% | 1 |
2 | BLOOD VASC INTERACTIONS | 179621 | 1% | 100% | 1 |
3 | CHEM ORGAN METALL CPDS | 179621 | 1% | 100% | 1 |
4 | KLIN SPORTORTHOPADIE SPORTTRAUMATOL | 179621 | 1% | 100% | 1 |
5 | LUDWIG BOLTZMANN ANGEW BADER KUMAHEILKUNDE | 179621 | 1% | 100% | 1 |
6 | MED HAEMOTHER Y HAEMOSTASIS | 179621 | 1% | 100% | 1 |
7 | MED PL BIOTECHNOL D CAMPANACCI | 179621 | 1% | 100% | 1 |
8 | MED RHEUMATOL PATHOL | 179621 | 1% | 100% | 1 |
9 | ORIENTAL MED BONE JOINT | 179621 | 1% | 100% | 1 |
10 | GC DESCOVICH ATHEROSCLEROSIS METAB DIS | 89809 | 1% | 50% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ACTA POLONIAE PHARMACEUTICA | 15177 | 6% | 1% | 11 |
2 | ARCHIV DER PHARMAZIE | 8180 | 8% | 0% | 14 |
3 | CHEMIKER-ZEITUNG | 3307 | 2% | 0% | 4 |
4 | KHIMIYA GETEROTSIKLICHESKIKH SOEDINENII | 1809 | 5% | 0% | 8 |
5 | JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS | 1219 | 2% | 0% | 4 |
6 | VASCULAR PHARMACOLOGY | 633 | 1% | 0% | 2 |
7 | INFLAMMATION RESEARCH | 573 | 2% | 0% | 3 |
8 | ARZNEIMITTELFORSCHUNG-DRUG RESEARCH | 569 | 1% | 0% | 2 |
9 | VETERINARY AND COMPARATIVE ONCOLOGY | 494 | 1% | 0% | 1 |
10 | IDRUGS | 480 | 1% | 0% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LICOFELONE | 1483135 | 10% | 49% | 17 | Search LICOFELONE | Search LICOFELONE |
2 | TEPOXALIN | 1207440 | 6% | 61% | 11 | Search TEPOXALIN | Search TEPOXALIN |
3 | 2 2 DIMETHYL 6 4 CHLOROPHENYL 7 PHENYL 2 3 DIHYDRO 1H PYRROLIZINE 5 YL ACETIC ACID | 898103 | 3% | 100% | 5 | Search 2+2+DIMETHYL+6+4+CHLOROPHENYL+7+PHENYL+2+3+DIHYDRO+1H+PYRROLIZINE+5+YL+ACETIC+ACID | Search 2+2+DIMETHYL+6+4+CHLOROPHENYL+7+PHENYL+2+3+DIHYDRO+1H+PYRROLIZINE+5+YL+ACETIC+ACID |
4 | ML3000 | 718482 | 2% | 100% | 4 | Search ML3000 | Search ML3000 |
5 | COX 5 LOX INHIBITOR | 404145 | 2% | 75% | 3 | Search COX+5+LOX+INHIBITOR | Search COX+5+LOX+INHIBITOR |
6 | CAS 156897 06 2 | 359241 | 1% | 100% | 2 | Search CAS+156897+06+2 | Search CAS+156897+06+2 |
7 | LOX COX INHIBITOR | 359241 | 1% | 100% | 2 | Search LOX+COX+INHIBITOR | Search LOX+COX+INHIBITOR |
8 | RWJ 20142 | 359241 | 1% | 100% | 2 | Search RWJ+20142 | Search RWJ+20142 |
9 | CYCLOOXYGENASE LIPOXYGENASE INHIBITOR | 239493 | 1% | 67% | 2 | Search CYCLOOXYGENASE+LIPOXYGENASE+INHIBITOR | Search CYCLOOXYGENASE+LIPOXYGENASE+INHIBITOR |
10 | ZLJ 6 | 239493 | 1% | 67% | 2 | Search ZLJ+6 | Search ZLJ+6 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DE BOEVER, S , NEIRINCKX, E , BAERT, K , DE BACKER, P , CROUBELS, S , (2009) PHARMACOKINETICS OF TEPOXALIN AND ITS ACTIVE METABOLITE IN BROILER CHICKENS.JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS. VOL. 32. ISSUE 1. P. 97 -100 | 14 | 82% | 5 |
2 | DING, CH , CICUTTINI, F , (2003) LICOFELONE MERCKLE.IDRUGS. VOL. 6. ISSUE 8. P. 802-808 | 13 | 76% | 15 |
3 | KULKARNI, SK , SINGH, VP , (2007) LICOFELONE-A NOVEL ANALGESIC AND ANTI-INFLAMMATORY AGENT.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 7. ISSUE 3. P. 251-263 | 17 | 40% | 32 |
4 | GIORGI, M , MENGOZZI, G , RAFFAELLI, A , SABA, A , (2011) CHARACTERIZATION OF IN VIVO PLASMA METABOLITES OF TEPOXALIN IN HORSES USING LC-MS-MS.JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. VOL. 56. ISSUE 1. P. 45-53 | 8 | 80% | 2 |
5 | CICERO, AFG , LAGHI, L , (2007) ACTIVITY AND POTENTIAL ROLE OF LICOFELONE IN THE MANAGEMENT OF OSTEOARTHRITIS.CLINICAL INTERVENTIONS IN AGING. VOL. 2. ISSUE 1. P. 73-79 | 15 | 43% | 14 |
6 | POLLOCK, CG , CARPENTER, JW , KOCH, DE , HUNTER, RP , (2008) SINGLE AND MULTIPLE-DOSE PHARMACOKINETICS OF TEPOXALIN AND ITS ACTIVE METABOLITE AFTER ORAL ADMINISTRATION TO RABBITS (ORYCTOLAGUS CUNICULUS).JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS. VOL. 31. ISSUE 2. P. 171 -174 | 6 | 100% | 3 |
7 | GIORGI, M , YE, GS , SGORBINI, M , CORAZZA, M , (2011) VALIDATION OF AN HPLC-FL METHOD FOR THE DETERMINATION OF TEPOXALIN AND ITS MAJOR METABOLITE IN HORSE PLASMA.JOURNAL OF CHROMATOGRAPHIC SCIENCE. VOL. 49. ISSUE 1. P. 79-83 | 6 | 86% | 1 |
8 | GOUDA, AM , ABDELAZEEM, AH , (2016) AN INTEGRATED OVERVIEW ON PYRROLIZINES AS POTENTIAL ANTI-INFLAMMATORY, ANALGESIC AND ANTIPYRETIC AGENTS.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. VOL. 114. ISSUE . P. 257 -292 | 16 | 27% | 0 |
9 | CICERO, AFG , DEROSA, G , GADDI, A , (2005) COMBINED LIPOXYGENASE/CYCLO-OXYGENASE INHIBITION IN THE ELDERLY - THE EXAMPLE OF LICOFELONE.DRUGS & AGING. VOL. 22. ISSUE 5. P. 393-403 | 16 | 31% | 15 |
10 | BANNWARTH, B , (2004) IS LICOFELONE, A DUAL INHIBITOR OF CYCLO-OXYGENASE AND 5-LIPOXYGENASE, A PROMISING ALTERNATIVE IN ANTI-INFLAMMATORY THERAPY?.FUNDAMENTAL & CLINICAL PHARMACOLOGY. VOL. 18. ISSUE 1. P. 125-130 | 10 | 53% | 4 |
Classes with closest relation at Level 1 |